Cargando…
Liver-Targeted Combination Therapy Basing on Glycyrrhizic Acid-Modified DSPE-PEG-PEI Nanoparticles for Co-delivery of Doxorubicin and Bcl-2 siRNA
Combination therapy based on nano-sized drug delivery system has been developed as a promising strategy by combining two or more anti-tumor mechanisms. Here, we prepared liver-targeted nanoparticles (GH-DPP) composed of 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-polyethylene glycol-polyetherimi...
Autores principales: | Tian, Guixiang, Pan, Ruiyan, Zhang, Bo, Qu, Meihua, Lian, Bo, Jiang, Hong, Gao, Zhiqin, Wu, Jingliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349772/ https://www.ncbi.nlm.nih.gov/pubmed/30723405 http://dx.doi.org/10.3389/fphar.2019.00004 |
Ejemplares similares
-
Preparation and Evaluation of the Cytoprotective Activity of Micelles with DSPE-PEG-C60 as a Carrier Against Doxorubicin-Induced Cytotoxicity
por: Xu, Beihua, et al.
Publicado: (2022) -
PinX1-siRNA/mPEG-PEI-SPION combined with doxorubicin enhances the inhibition of glioma growth
por: LONG, LING, et al.
Publicado: (2014) -
Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma
por: Höbel, Sabrina, et al.
Publicado: (2011) -
Fluorinated PEG-PEI Coated Magnetic Nanoparticles for siRNA Delivery and CXCR4 Knockdown
por: Cao, Yixiang, et al.
Publicado: (2022) -
Antiproliferative activity of CD44 siRNA-PEI-PEG nanoparticles in glioblastoma: involvement of AKT signaling
por: Mahinfar, Parvaneh, et al.
Publicado: (2021)